Analyst Observations
Published: March 12, 2026
This content is for informational purposes only. This should not be construed as solicitation. The general public should consult their financial advisor for additional information related to investment decisions.
Comments include: ALNY, CE, CVX, DELL, GE, MS, SPG, & TMO.

 

ALNY Alnylam Pharmaceuticals Inc. ($313.05) - Biomedics/Genetics - ALNY inched lower to complete a double bottom break at $312. The 2 for 5'er moved down from a 3 last month after reversing back into a negative trend. Additionally, the stock ranks near the bottom of the biomedics/genetics sector matrix. A sell can be considered here. Initial resistance can be seen at $328, with additional resistance at $344.
CE Celanese Corporation ($59.38) - Chemicals - CE returned to a buy signal and a positive trend Thursday when it broke a double top at $56. The positive trend change will promote CE to a still unfavorable 2 for 5'er. From here, the next level of overhead resistance sits at $61.
CVX Chevron Corporation ($196.97) - Oil - CVX gave a fourth consecutive buy signal and reached a new all-time high on Thursday when it broke a double top at $194. Thursday's move adds to an already positive technical outlook as CVX is a 3 for 5'er and ranks in the top quartile of the oil sector matrix. However, the stock is now heavily extended with a weekly OBOS reading approaching 120%.
DELL Dell Technologies Inc Class C ($149.91) - Computers - Shares of DELL have improved notably over the last several weeks, and today's action saw the stock break a double top at $150 to return to a buy signal. The 5 for 5'er moved into a positive trend while regaining most of its relative strength over the last month, taking it back to strong buy territory. However, the stock is now in overbought territory, so those looking to add should wait for pullback or consolidation. Support starts at $138 while initial resistance lies at $152.
GE GE Aerospace ($304.27) - Aerospace Airline - Quick comment for GE today as the 4/5'er has posted its second consecutive sell signal on its default chart. While the development certainly isn't bullish by any means, we have still put in a series of higher lows coming of recent December bottoms. Keep a close eye on the name for further technical deterioration... but you're fine to maintain exposure for now. Support is found at the 2026 lows around $292.
MS Morgan Stanley ($153.63) - Wall Street - MS shares moved lower today to break a double bottom at $154 to mark its third consecutive sell signal. This 4 for 5'er moved to a negative trend last week but maintains an RS buy signal versus the market that has been in place since June 2013. MS shares are trading in heavily oversold territory. From here, support is offered at $152.
SPG Simon Property Group, Inc. ($187.57) - Real Estate - Shares of SPG moved lower during Thursday's trading, completely its second consecutive sell signal. Additionally, today's action saw the stock flip its trend back to negative, bringing it down to a 4 for 5'er. However, for the time being, the stock remains more a buy given its market and peer relative strength. Initial support starts at $182.
TMO Thermo Fisher Scientific Inc. ($476.77) - Healthcare - TMO inched lower to complete a triple bottom break at $488, marking its second consecutive sell signal. The 2 for 5'er moved down from a 4 last month after moving back into a negative trend and reversing into a column of Os against the market. The weekly OBOS indicates that the stock is in oversold territory, so wait for the 10-week trading band to normalize before selling your position. Strong resistance can be seen at $520. The bearish resistance line can be seen at $608.
Back to report

DISCLOSURE

This report is for Internal Use Only and not for distribution to the public. While we make every effort to be free of errors in this report, it contains data obtained from other sources. We believe these sources to be reliable, but we cannot guarantee their accuracy. Investors who use options should read the Options Disclosure Document before making any particular investment decision. Officers or employees of this firm may now or in the future have a position in the stocks mentioned in this report. Dorsey, Wright is a Registered Investment Advisor with the U.S. Securities & Exchange Commission. Copies of Form ADV Part II are available upon request.
Equity prices provided by Thomson-Reuters. Cross Rate prices provided by Tenfore Systems. Option prices provided by OPRA
Copyright © 1995-2026 Dorsey, Wright & Associates, LLC.®
All quotes displayed are delayed 20 minutes
Disclaimer/Terms of Use/Copyright